Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCQB:PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has received allowance from the United States Patent and Trademark Office (USPTO) of its patent application protecting the synthetic process used to produce the small molecule Rose Bengal. A notice of allowance is issued after the USPTO makes a determination that a patent can be granted.
Help employers find you! Check out all the jobs and post your resume.
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCQB:PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has received allowance from the United States Patent and Trademark Office (USPTO) of its patent application protecting the synthetic process used to produce the small molecule Rose Bengal. A notice of allowance is issued after the USPTO makes a determination that a patent can be granted.
Help employers find you! Check out all the jobs and post your resume.